Low concentrations of STI571 in the cerebrospinal fluid: a case report.
about
Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: case reportMetastatic cerebellar gastrointestinal stromal tumor with obstructive hydrocephalus arising from the small intestine: a case report and review of the literatureCentral nervous system blast crisis in chronic myeloid leukemia on imatinib mesylate therapy: report of two cases.Dasatinib as the salvage therapy for chronic myeloid leukemia with blast crisis and central nervous system involvement: A case reportCancer treatment with kinase inhibitors: what have we learnt from imatinib?Mechanisms of resistance to STI571 (Imatinib) in Philadelphia-chromosome positive acute lymphoblastic leukemia.Philadelphia positive acute lymphoblastic leukaemia of childhood.Central nervous system is a sanctuary site for chronic myelogenous leukaemia treated with imatinib mesylate.New developments in the treatment of chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia.Managing Philadelphia chromosome-positive acute lymphoblastic leukemia: role of tyrosine kinase inhibitors.Brain metastasis from gastrointestinal stromal tumor: a case report and review of the literature.Potential mechanisms of disease progression and management of advanced-phase chronic myeloid leukemia.Blast phase transformation of chronic myelogenous leukemia presenting with central nervous system manifestation.KIT as a therapeutic target in melanoma.Interaction of the multikinase inhibitors sorafenib and sunitinib with solute carriers and ATP-binding cassette transportersSunitinib treatment for multiple brain metastases from jejunal gastrointestinal stromal tumor: case report.Chronic myeloproliferative disorders with rearrangement of the platelet-derived growth factor alpha receptor: a new clinical target for STI571/Glivec.Efficacy and safety of imatinib mesylate (Glivec) in combination with interferon-alpha (IFN-alpha) in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL).Isolated central nervous system relapse in lymphoid blast crisis chronic myeloid leukemia and acute lymphoblastic leukemia in patients on imatinib therapy.Central nervous system relapse in two patients with chronic myelogenous leukemia in myeloid blastic phase on imatinib mesylate therapy.Dasatinib maintenance therapy after allogeneic hematopoietic stem cell transplantation for an isolated central nervous system blast crisis in chronic myelogenous leukemia.Characterisation of extramedullary relapse in patients with chronic myeloid leukemia in advanced disease after allogeneic stem cell transplantation.Isolated central nervous system relapse in patients with chronic myeloid leukemia on imatinib mesylate.Remission of Philadelphia chromosome-positive central nervous system leukemia after dasatinib therapy.Isolated central nervous system relapse in patient with blast-crisis chronic myeloid leukemia in durable complete cytogenetic remission on dasatinib treatment: pharmacokinetics and ABL mutation analysis in cerebrospinal fluid.Effects of chemotherapeutics on organotypic corticostriatal slice cultures identified by a panel of fluorescent and immunohistochemical markers.Taming of the shrew--overcoming extramedullary blast crisis in the era of the new tyrosine kinase inhibitors.Presentation of extramedullary Philadelphia chromosome-positive biphenotypic acute leukemia as testicular mass: Response to imatinib-combined chemotherapy.
P2860
Q24804492-F4B09292-ABFE-4C80-B66D-677A645BFFADQ30885557-EC3751A2-55AD-4A08-90DA-FBA4B256A5F0Q35008722-C0C3C45B-26B0-461D-B90E-B277155A5E1CQ35167824-C0EE18A9-D388-4B1E-97E2-3A6458D26C54Q35622440-76066A8E-169B-4FA7-8D35-788204DC5647Q35782565-7F21BEC2-4B90-4EBF-862C-1EA08895314BQ36228062-E91048B6-978A-44B0-9902-510202D5FD38Q37542362-06A8BE7F-F8D5-4EE3-B0A1-696A1AD51CCEQ37836938-CFEACC40-DC93-4CEB-A287-E69EA838491AQ37875969-D0F0E91A-A628-4017-B84F-232851E4DED1Q37959953-A9106CC5-7070-45D2-9EA4-880153676332Q38139571-7A1573DD-E759-48A3-9884-6E06E0D185DBQ38738491-6395C8CE-1F3F-4D86-9CA8-EEDFDB1A7958Q39364958-377569CD-A1AE-40FC-BC48-BE0464D58181Q41808513-B4B38976-231A-4C4C-9B4F-4452DEA5BC30Q42137803-749CBF06-3A87-4EA1-B5A4-6AE23D04EAD6Q44566239-E4B285D0-79C6-4476-8BD3-85487D42238AQ44598654-2E320669-0FAA-449F-8B7C-2A084E19BDD2Q44854228-81979121-8635-4E82-99B5-6ED07EDAAABBQ45061059-B2A7D0C3-73E2-4E14-BB28-03D8562FD071Q45395361-170F955A-AF4C-4904-AC7B-EE5EAEC32511Q46047569-D5F9EE89-7A18-4CD1-8C8A-00334A18C4C6Q46600609-CD0BAB9C-7A95-435E-B5F9-9466039766F9Q48175008-33938FFB-0D3A-4B1E-9D57-55EA97CA8ACDQ48274819-076DC6D4-8C1F-4C5C-9F84-6EBABFA2655BQ48744925-5DE7C7C9-A6F6-4642-8508-252A1AD61CF3Q54440145-B24E02D9-7778-4514-8C1C-627E2AC3925BQ54664160-91B82712-ECC0-4332-8745-D15A6E7573C0
P2860
Low concentrations of STI571 in the cerebrospinal fluid: a case report.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Low concentrations of STI571 in the cerebrospinal fluid: a case report.
@en
Low concentrations of STI571 in the cerebrospinal fluid: a case report.
@nl
type
label
Low concentrations of STI571 in the cerebrospinal fluid: a case report.
@en
Low concentrations of STI571 in the cerebrospinal fluid: a case report.
@nl
prefLabel
Low concentrations of STI571 in the cerebrospinal fluid: a case report.
@en
Low concentrations of STI571 in the cerebrospinal fluid: a case report.
@nl
P2093
P2860
P1476
Low concentrations of STI571 in the cerebrospinal fluid: a case report.
@en
P2093
Andreas L Petzer
Eberhard Gunsilius
Folker Schneller
Guenther Gastl
Guenther Stockhammer
Hans C H Duba
Kurt Grünewald
Michael Hayes
P2860
P304
P356
10.1046/J.1365-2141.2002.03523.X
P407
P50
P577
2002-06-01T00:00:00Z